A new market study, titled “Proteomics: Technologies and Global Markets” has been featured on WiseGuyReports.
In May 2014, two independent research groups, one in the U.S. and India, and the other in Germany, published the first drafts of the human proteome, which was based on mass spectrometry data. These maps were the most comprehensive to date and signaled the rapid progress in our understanding of the role of genes and their products, proteins.
The draft human proteome signaled the coming of age of proteomics, a field that is rapidly transitioning from research and development application to more applied fields including diagnostics.
The two key proteomics technologies — mass spectrometry and biochips — are benefiting from an explosion of new proteomics content from the large-scale genomic and proteomic initiatives. For instance, according to the Journal of Proteome Research, ACS Publications, the Human Proteome Organization (HUPO) has introduced the Proteomics Standards Initiative (PSI) that is exploring software tools and open community standards in proteomics over the last 15 years (from 2002). Further, HUPO is also credited with completing protein parts list for the draft human proteome. In addition, HUPO is also exploring the application of proteomics for integration with genomics and transcriptomics across life sciences and biomedical research. This proteomics content is driving the discovery of new biomarkers that are important in disease diagnostic processes such as cancer diagnostics, myocardial infarction, congestive heart failure, and others.
Novel technologies are also driving proteomics applications. For example, increasing miniaturization and integration is occurring in biochip devices, and improvements in mass spectrometry workflow and instruments. These innovations are driving proteomics applications in important markets like drug discovery and development and diagnostics. For instance, in 2017, as per the European Association of Urology, the Israeli Institute of Technology developed a silicon biosensor chip that can identify the best antibiotics in just a few hours instead of days and can help in treating a bacterial infection. Furthermore, in 2017, the Georgia Institute of Technology presented that replacing conventional power supplies with Triboelectric Nano-generators (TENG) for charging molecules can boost up sensitivity of mass spectrometers and can also help in identification of small volumes.
Request Sample Report at https://www.wiseguyreports.com/sample-request/3398634-proteomics-technologies-and-global-markets
The study scope covers MS instruments, consumables, workflow products, planar arrays, bead arrays, and LOCs. It also covers the research, drug discovery and development, diagnostics, and applied end-user market segments. The main geographical markets—North America, Europe, Asia-Pacific, and Rest of the World (ROW)—are included.
The MS market is covered by instrument type, MS consumables, and product type and end-user markets. The biochip market is covered by biochip type and the end-user market for each type. The diagnostics market is covered in some detail, including by major platform (i.e., MS, biochips), by disease type and for cancer by indication. This report provides the current market sizes for these segments, as well as their forecasted growth through 2022.
Technology status and forces driving the market are discussed and analyzed. Factors that influence each market are also highlighted, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs, and competitive trends.
Key industry acquisitions and strategic alliances are given for the three-year period from 2015 through 2018.
This report also examines the main patent trends within the industry and profiles 108 proteomics companies.
View Detailed Report at https://www.wiseguyreports.com/reports/3398634-proteomics-technologies-and-global-markets
– 20 data tables and 62 additional tables
– An overview of the global proteomics market, which covers: technologies, platform and software markets, disease markets, biochip markets and end-use industry markets
– Analyses of global market trends, with data from 2016 and 2017, and projections of CAGRs through 2022
– Examination of market trends and opportunities that will impact the future market
– A look at proteomics scientific initiatives, industry acquisitions and patents
– Discussion of proteomic applications in drug discovery and development
– Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.
– Company profiles of major players, including Abcodia Ltd., Bruker Corp., Digilab Inc., Glaxosmithkline Plc., & Luminex Corp.
Table of Contents
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Overview
Chapter 4 Proteomics Technologies
Chapter 5 Proteomics Applications in Drug Discovery and Development
Chapter 6 Proteomics Scientific Initiatives
Chapter 7 Clinical Proteomics Applications
Chapter 8 Proteomics Industry
Chapter 9 Proteomics Markets
Chapter 10 Proteomics Patents
Chapter 11 Company Profiles
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)